Public trial registry of the CCC-Munich

Trial IMCL CP12-0919

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
IMCL CP12-0919
World
Full title
:

HCC, Hepatozelluläres Karzinom, A Multicenter, Randomized, Double-Blind, Phase 3 Study of Ramucirumab (IMC-1121B) Drug Product and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma Following First-Line Therapy With Sorafenib, REACH

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Klinik für Radiologie, Telefon: 089440072750
Indications
Classification Code Description
ICD-10-GM C22.0 Leberzellkarzinom
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Blinded
World
Phase
:
III
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2015-03-31 / Unknown
Therapy
World
Therapy line
:
2
Participants
Function Prename Surname Organization
World Principal Investigator VOLKER HEINEMANN Keine Organisationseinheit angegeben Magnifier